Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers Article

Badr, Haitham A, AlSadek, Dina MM, Darwish, Ashraf A et al. (2014). Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers . EXPERT REVIEW OF PROTEOMICS, 11(2), 227-236. 10.1586/14789450.2014.897611

cited authors

  • Badr, Haitham A; AlSadek, Dina MM; Darwish, Ashraf A; ElSayed, Abdelaleim I; Bekmanov, Bakhytzhan O; Khussainova, Elmira M; Zhang, Xueji; Cho, William CS; Djansugurova, Leyla B; Li, Chen-Zhong

authors

publication date

  • April 1, 2014

published in

keywords

  • AFFINITY
  • Biochemical Research Methods
  • Biochemistry & Molecular Biology
  • GLYCOSYLATION
  • IDENTIFICATION
  • Life Sciences & Biomedicine
  • MALIGNANCY ALGORITHM
  • N-GLYCAN
  • OVARIAN-CANCER
  • PROSTATE-SPECIFIC ANTIGEN
  • PROTEIN 4
  • QUANTITATIVE-ANALYSIS
  • SERUM THYROGLOBULIN
  • Science & Technology
  • biomarkers
  • cancer
  • diagnosis
  • glycoproteome
  • lectins

Digital Object Identifier (DOI)

publisher

  • TAYLOR & FRANCIS LTD

start page

  • 227

end page

  • 236

volume

  • 11

issue

  • 2